<DOC>
	<DOCNO>NCT01726296</DOCNO>
	<brief_summary>This clinical trial study adherence survivorship care guideline health care provider non-small cell lung cancer colorectal cancer survivor care . The completion educational intervention health care provider may increase compliance adherence National Comprehensive Cancer Network guideline survivorship care .</brief_summary>
	<brief_title>Adherence Survivorship Care Guidelines Health Care Providers Non-Small Cell Lung Cancer Colorectal Cancer Survivor Care</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate adherence oncology health care provider National Comprehensive Cancer Network ( NCCN ) guideline cancer survivorship care colorectal cancer ( CRC ) non-small cell lung cancer ( NSCLC ) cancer . SECONDARY OBJECTIVES : I . To develop assess target educational initiative improve compliance NCCN CRC NSCLC survivorship guideline oncology health care provider academic community practice . II . To evaluate impact educational initiative document adherence compliance NCCN guideline NSCLC CRC survivorship care oncology health care provider . OUTLINE : Health care provider complete educational intervention base NCCN guideline CRC NSCLC survivorship care comprise power point presentation review evidence guideline ; USB drive NCCN guideline paper copy page address survivorship care ; electronic paper copy sample survivorship clinic template note prompt address survivorship care component ; electronic paper copy sample survivorship care plan adapt distribute participate site .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma , Mucinous</mesh_term>
	<mesh_term>Cystadenocarcinoma</mesh_term>
	<criteria>HEALTH CARE PROVIDER INCLUSION CRITERIA : Any health care provider ( physician , advanced practice clinician ) study site ( Fox Chase Cancer Center [ FCCC ] Fox Chase Cancer Center Partners [ FCCCP ] ) provide care NSCLC and/or CRC survivor CHART AUDIT INCLUSION CRITERIA ( BASELINE ) : Cancer Registry case include stage IIII colon cancer ( adenocarcinoma histology ) , stage IIII rectal cancer ( adenocarcinoma histology ) , stage IIII nonsmall cell lung cancer ( squamous adenocarcinoma histology ) Patients must complete therapy curative intent least six month prior chart audit Undergoing routine oncology care surveillance choose site ( defined receive followup care FCCC FCCCP site health care provider active medical chart ) No evidence metastatic disease Patients must see visit cancer surveillance 2009 2013 Health care provider participate site must willing able participate educational initiative CHART AUDIT INCLUSION CRITERIA ( POSTINTERVENTION ) Charts eligible audit completion educational initiative CRC NSCLC survivor present followup initiative complete site health care provider CHART AUDIT EXCLUSION CRITERIA : Cancer Registry case diseases colon rectal adenocarcinoma nonsmall cell lung cancer ( squamous adenocarcinoma histology ) Patients currently receive active therapy cancer , include CRC NSCLC Patients undergo routine oncologic care choose Partners site Fox Chase Cancer Center Stage IV cancer evidence metastatic disease time point Patients undergone visit cancer surveillance since 2009 Fox Chase Cancer Partners sit agree chart audit procedure provider unable unwilling participate educational initiative</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>